Contact
Please use this form to send email to PR contact of this press release:
Navrogen Awarded National Cancer Institute Grant to Develop Next-Generation Rituximab With Enhanced Therapeutic Effects
TO:
Steven Kyriakos, VP of Finance & Operations
Navrogen, Incorporated
+1 610-399-2717